These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39429237)

  • 21. Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.
    Kurcova S; Bardon J; Vastik M; Vecerkova M; Frolova M; Hvizdosova L; Nevrly M; Mensikova K; Otruba P; Krahulik D; Kurca E; Sivak S; Zapletalova J; Kanovsky P
    Medicine (Baltimore); 2018 Feb; 97(5):e9750. PubMed ID: 29384860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson's disease.
    Kim R; Kim HJ; Shin C; Park H; Kim A; Paek SH; Jeon B
    J Neurosurg; 2019 Dec; 131(6):1797-1804. PubMed ID: 30641837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Clinical Study of Patients with Primary Parkinson's Disease Undergoing Bilateral Deep Brain Stimulation (STN-DBS) Surgery in the Subthalamic Nucleus under General Anesthesia].
    Shi YF; Zhang Y; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):583-587. PubMed ID: 35871727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
    J Neurosurg; 2021 Nov; 135(5):1429-1435. PubMed ID: 33607613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Brain Morphometry Predictors of Deep Brain Stimulation Outcome in Parkinson's Disease.
    Koivu M; Sihvonen AJ; Eerola-Rautio J; Pauls KAM; Resendiz-Nieves J; Vartiainen N; Kivisaari R; Scheperjans F; Pekkonen E
    Brain Topogr; 2024 Nov; 37(6):1186-1194. PubMed ID: 38662300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term follow-up in advanced Parkinson's disease treated with DBS of the subthalamic nucleus.
    Volonté MA; Clarizio G; Galantucci S; Scamarcia PG; Cardamone R; Barzaghi LR; Falautano M; Mortini P; Comi G; Filippi M
    J Neurol; 2021 Aug; 268(8):2821-2830. PubMed ID: 33598766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson's Disease.
    Rolland AS; Touzet G; Carriere N; Mutez E; Kreisler A; Simonin C; Kuchcinski G; Chalhoub N; Pruvo JP; Defebvre L; Reyns N; Devos D; Moreau C
    J Parkinsons Dis; 2024; 14(1):111-119. PubMed ID: 38189764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-motor Adverse Effects Avoided by Directional Stimulation in Parkinson's Disease: A Case Report.
    Alonso-Frech F; Fernandez-Garcia C; Gómez-Mayordomo V; Monje MHG; Delgado-Suarez C; Villanueva-Iza C; Catalan-Alonso MJ
    Front Neurol; 2021; 12():786166. PubMed ID: 35173666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directional Stimulation in Parkinson's Disease and Essential Tremor: The Cleveland Clinic Experience.
    Rammo RA; Ozinga SJ; White A; Nagel SJ; Machado AG; Pallavaram S; Cheeran BJ; Walter BL
    Neuromodulation; 2022 Aug; 25(6):829-835. PubMed ID: 33733515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Eriksson B; Jansson Y; Johnels B; Holmberg B; Gudmundsdottir T; Renck A; Berglund P; Bergquist F
    Clin Neurol Neurosurg; 2017 Mar; 154():43-48. PubMed ID: 28113102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's Disease Motor Subtypes Show Different Responses to Long-Term Subthalamic Nucleus Stimulation.
    Xu C; Zhuang P; Hallett M; Zhang Y; Li J; Li Y
    Front Hum Neurosci; 2018; 12():365. PubMed ID: 30337863
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson's disease: 7-year follow-up.
    Ehm G; Kim HJ; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Lim YH; Jeon B; Paek SH
    J Neurosurg; 2019 Nov; 131(5):1508-1513. PubMed ID: 30497175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep Brain Stimulation for Parkinson's Disease: Currents Status and Emerging Concepts.
    Doshi PK; Das D
    Neurol India; 2020; 68(Supplement):S179-S186. PubMed ID: 33318348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.